Prebiotic inulin for individuals on weight loss medications

Obesity is a leading public health issue in the US that profoundly impacts health and people’s lives. Cardiovascular health, diabetes and other aspects such as a person’s appearance may negatively be affected. Increasingly, medications intended for type 2 diabetes (like GLP-1RAs) are being utilized as anti-obesity or weight loss treatments and can significantly support weight loss (up to 15%). Chicory inulin and oligofructose may aid individuals experiencing various side effects from these new medications and, in general, help with weight management.

Download the Sensus leaflet: Prebiotic inulin support for individuals on weight loss medications.